In recent years, the Chinese pharmaceutical market has seen strong demand and sustained high growth. At the same time, high-end manufacturing in China is also shifting from domestic substitution to global supply. Jingtai Capital is optimistic about t...

2021 has passed, and 2022 is quietly coming. Jingtai capital is optimistic about the domestic semiconductor market. The semiconductor industry is in short supply, and the market space is huge. In particular, the national policy encourages domestic se...